Brown, Lisle/Cummings’s Labcorp LH Stock Holding History

Brown, Lisle/Cummings’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.2K	Buy	315 +4	+1%	+$1.05K	0.02%	317
2026 Q1	$83K	Buy	311 +11	+4%	+$2.98K	0.02%	302
2025 Q4	$75.3K	Hold	300	–	–	0.02%	306
2025 Q3	$86.1K	Hold	300	–	–	0.02%	293
2025 Q2	$78.8K	Hold	300	–	–	0.02%	294
2025 Q1	$69.8K	Hold	300	–	–	0.02%	301
2024 Q4	$68.8K	Hold	300	–	–	0.02%	300
2024 Q3	$67K	Hold	300	–	–	0.02%	294
2024 Q2	$61.1K	Hold	300	–	–	0.02%	298
2024 Q1	$65.5K	Hold	300	–	–	0.02%	271
2023 Q4	$68.2K	Hold	300	–	–	0.03%	262
2023 Q3	$60.3K	Sell	300 -49	-14%	-$10.3K	0.03%	255
2023 Q2	$72.4K	Hold	349	–	–	0.03%	251
2023 Q1	$68.8K	Hold	349	–	–	0.03%	249
2022 Q4	$70.6K	Buy	349 +145	+71%	+$28.3K	0.04%	240
2022 Q3	$35.8K	Buy	204 +58	+40%	+$11.9K	0.02%	279
2022 Q2	$29.3K	Hold	146	–	–	0.02%	293
2022 Q1	$33K	Buy	146 +88	+152%	+$20.7K	0.02%	301
2021 Q4	$15.7K	Buy	+58	New	+$14.4K	0.01%	351

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brown, Lisle/Cummings's LH Position: Q2 2026 in Review

Brown, Lisle/Cummings increased its Labcorp (LH) stake by 1.3% in Q2 2026, buying an estimated $1.05K and bringing the position to 315 shares worth $88.2K. The position accounts for 0.02% of the portfolio, ranked #317.

Brown, Lisle/Cummings first reported a position in LH in Q4 2021 and has held it in 19 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Brown, Lisle/Cummings held 315 shares of Labcorp worth $88.2K as of Q2 2026.
Brown, Lisle/Cummings bought 4 Labcorp shares in Q2 2026, an estimated $1.05K.
Labcorp made up 0.02% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #317 holding.
Brown, Lisle/Cummings first reported a position in Labcorp in Q4 2021 and has held it in 19 quarters since.
1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.